[go: up one dir, main page]

HK1006945A1 - Improvements in or relating to contrast agents - Google Patents

Improvements in or relating to contrast agents

Info

Publication number
HK1006945A1
HK1006945A1 HK98106127A HK98106127A HK1006945A1 HK 1006945 A1 HK1006945 A1 HK 1006945A1 HK 98106127 A HK98106127 A HK 98106127A HK 98106127 A HK98106127 A HK 98106127A HK 1006945 A1 HK1006945 A1 HK 1006945A1
Authority
HK
Hong Kong
Prior art keywords
pct
contrast agents
relating
sec
date
Prior art date
Application number
HK98106127A
Other languages
English (en)
Inventor
Lars Stubberud
Jo Klaveness
Per Strande
Arne Berg
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26299192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1006945(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919114565A external-priority patent/GB9114565D0/en
Priority claimed from GB929200386A external-priority patent/GB9200386D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of HK1006945A1 publication Critical patent/HK1006945A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98106127A 1991-07-05 1998-06-23 Improvements in or relating to contrast agents HK1006945A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919114565A GB9114565D0 (en) 1991-07-05 1991-07-05 Improvements in or relating to contrast agents
GB929200386A GB9200386D0 (en) 1992-01-09 1992-01-09 Improvements in or relating to contrast agents
PCT/EP1992/001477 WO1993000930A1 (en) 1991-07-05 1992-07-03 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
HK1006945A1 true HK1006945A1 (en) 1999-03-26

Family

ID=26299192

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106127A HK1006945A1 (en) 1991-07-05 1998-06-23 Improvements in or relating to contrast agents

Country Status (15)

Country Link
US (2) US5607661A (xx)
EP (1) EP0593624B1 (xx)
JP (1) JPH06510758A (xx)
AT (1) ATE151993T1 (xx)
AU (1) AU675050B2 (xx)
CA (1) CA2112109A1 (xx)
DE (1) DE69219337T2 (xx)
DK (1) DK0593624T3 (xx)
ES (1) ES2103376T3 (xx)
FI (1) FI940027L (xx)
GR (1) GR3023394T3 (xx)
HK (1) HK1006945A1 (xx)
IE (1) IE80926B1 (xx)
NO (1) NO940015L (xx)
WO (1) WO1993000930A1 (xx)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
JP3231768B2 (ja) * 1991-09-17 2001-11-26 ソーナス ファーマシューティカルス，インコーポレイテッド 気体状超音波造影剤及び超音波造影剤として使用する気体の選定方法
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
JP3621413B2 (ja) * 1993-01-25 2005-02-16 アマシャム・ヘルス・エーエス 超音波造影剤としての相転移コロイド
EP0711179B2 (en) * 1993-07-30 2010-09-01 IMCOR Pharmaceutical Co. Stabilized microbubble compositions for ultrasound
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US5897851A (en) * 1995-06-07 1999-04-27 Sonus Pharmaceuticals, Inc. Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
DE19602930A1 (de) * 1996-01-18 1997-07-24 Schering Ag Poröse Matrices aus niedermolekularen Substanzen zur Genierung stabiler Gasblasensuspensionen, deren Verwendung als Ultraschallkontrastmittel sowie Verfahren zu deren Herstellung
DK0904113T3 (da) * 1996-03-05 2004-08-30 Acusphere Inc Mikroindkapslede fluorerede gasser til anvendelse som billeddannende midler
GB9622711D0 (en) 1996-10-31 1997-01-08 British Tech Group Instrument having enhanced ultrasound visibility
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
WO1999042138A1 (en) * 1998-02-19 1999-08-26 University Of Virginia Patent Foundation The use of bjerknes forces to manipulate contrast agents
CA2410887C (en) 2000-06-02 2012-07-24 Bracco Research Usa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
EP1387637B1 (en) * 2001-04-06 2007-10-31 Bracco Research S.A. Apparatus for measuring local physical parameters in a fluid filled cavity
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
WO2003074005A2 (en) 2002-03-01 2003-09-12 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
AU2003278807A1 (en) 2002-03-01 2004-08-13 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
JP5466350B2 (ja) 2003-03-03 2014-04-09 ダイアックス、コープ ＨＧＦレセプター（ｃＭｅｔ）を特異的に結合するペプチドおよびその使用
SE526838C2 (sv) * 2003-11-27 2005-11-08 Xcounter Ab Undersökningsmetod och anordning för detektion av joniserande strålning
US20050255175A1 (en) * 2004-05-17 2005-11-17 Burgess W P Method for protecting nephron against injury caused by disruption of a chemical environment in the kidneys
US7019035B2 (en) * 2004-05-17 2006-03-28 Md Scientific Llc Method for attenuating free radical formation resulting from bodily insult
US20050255176A1 (en) * 2004-05-17 2005-11-17 Burgess W P Method for attenuating free radical formation resulting from bodily insult
US7625586B2 (en) 2004-10-28 2009-12-01 Md Scientific, Llc Method for mitigating injury to a kidney resulting from an ischemic event
US7999134B2 (en) * 2009-07-21 2011-08-16 Ge Healthcare As Crystallization of iodixanol using milling
US9827265B1 (en) 2012-04-06 2017-11-28 Md Scientific, Llc Method for attenuating free radical formation resulting from a bodily insult
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
DK3185876T3 (da) 2014-08-28 2022-10-31 Massachusetts Gen Hospital Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
SG10201913504XA (en) 2016-02-26 2020-03-30 Massachusetts Gen Hospital Medical ice slurry production and delivery systems and methods
JP7211699B2 (ja) * 2017-09-11 2023-01-24 バイエル ファーマ アクチエンゲゼルシャフト 超音波診断用造影剤
US11241330B1 (en) 2021-04-02 2022-02-08 Brixton Biosciences, Inc. Apparatus for creation of injectable slurry

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680133A (en) * 1951-08-24 1954-06-01 Mallinckrodt Chemical Works Iodine-containing amino-benzoyl derivatives of amino acids
DE2629228C2 (de) * 1976-06-25 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Jodierte Isophthalamsäure-Derivate Verfahren zu deren Herstellung sowie deren Verwendung
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
ATE17311T1 (de) * 1980-11-17 1986-01-15 Schering Ag Praeparat zur erzeugung von mikroblaeschen.
US4572203A (en) * 1983-01-27 1986-02-25 Feinstein Steven B Contact agents for ultrasonic imaging
DE3313946A1 (de) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
DE3834705A1 (de) * 1988-10-07 1990-04-12 Schering Ag Ultraschallkontrastmittel aus gasblaeschen und fettsaeure enthaltenden mikropartikeln
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US5354549A (en) * 1987-07-24 1994-10-11 Nycomed Imaging As Iodinated esters
DE3828905A1 (de) * 1988-08-23 1990-03-15 Schering Ag Mittel bestehend aus cavitate oder clathrate bildenden wirt/gast-komplexen als kontrastmittel
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters
US5215680A (en) * 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
US5205290A (en) * 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5233995A (en) * 1991-11-21 1993-08-10 Sterling Winthrop Inc. Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods

Also Published As

Publication number Publication date
FI940027A0 (fi) 1994-01-04
DE69219337D1 (de) 1997-05-28
US5607661A (en) 1997-03-04
GR3023394T3 (en) 1997-08-29
DE69219337T2 (de) 1997-10-09
DK0593624T3 (da) 1997-05-20
JPH06510758A (ja) 1994-12-01
AU675050B2 (en) 1997-01-23
CA2112109A1 (en) 1993-01-21
ES2103376T3 (es) 1997-09-16
EP0593624A1 (en) 1994-04-27
WO1993000930A1 (en) 1993-01-21
AU2277292A (en) 1993-02-11
IE80926B1 (en) 1999-06-30
FI940027L (fi) 1994-01-04
ATE151993T1 (de) 1997-05-15
IE922179A1 (en) 1993-01-13
NO940015D0 (no) 1994-01-04
EP0593624B1 (en) 1997-04-23
NO940015L (no) 1994-01-04
US5772984A (en) 1998-06-30

Similar Documents

Publication Publication Date Title
GR3023394T3 (en) Improvements in or relating to contrast agents
GB9415554D0 (en) Cobalt on alumina catalysts
BR9307734A (pt) Formulações injetáveis aquosas úteis para radiodiagnose compreendendo compostos aromáticos iodados usadas como meio de contraste de raio x
AU3506893A (en) Use of fullerenes in diagnostic and/or therapeutic agents
FR2722506B1 (fr) Composition contenant des acides nucleiques, preparation et utilisations
DE69621596D1 (de) Antimikrobielles mittel bestehend aus gläser mit kontrollierter abgabe
EP0544819A4 (en) Indole derivatives which inhibit leukotriene biosynthesis
LTIP609A (en) Multinuclear complexes, contrast media containing them and use
GR3034991T3 (en) Dihydrobenzofuranes
GR3031109T3 (en) Triphenylethylenes for the prevention and treatment of osteoporosis
PL337803A1 (en) Pharmaceutic agents containing eletriptane hemisulphate and caffeine
PL310171A1 (en) Novel imidazopyridines
IL104526A0 (en) Spray-chilled nabumetone and pharmaceutical compositions containing it
GR3020473T3 (en) Dermatological and/or cosmetological composition containing retinoids.
ES2118934T3 (es) Medios de contraste.
HUT59015A (en) Contrast medium comprising non-ionic contrast material
AU2320392A (en) Hydroxamate and hydrazide derivatives of polyamines and their medical use as chelating agents
GR3026324T3 (en) Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered.
MX9203100A (es) Nuevos peptidos, su preparacion y su aplicacion.
RS49734B (sr) Primena intravenoznih kontrastnih sredstava za projekcionu mamografiju
DE69319337D1 (en) Polyetheramidoamine hydrogele als heparinersatz
FR2754715B1 (fr) Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
DK0614457T3 (xx)

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)